Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Self-care in leprosy from the perspective of operative groups: a qualitative approach

Souza NMN, de Lima Belmonte M, Alves MGT, et al. Online Brazilian Journal of Nursing. 2021;
Download PDF
Publication

Lepra: las repercusiones diarias en las trayectorias de la vida

Pimentel RRDS, Sanches RDCN, Radovanovic CAT, et al. Universidad de Alicante Servicio de Publicaciones. Cultura de los Cuidados. 2021;
Download PDF
Publication

Aiming for Zero Leprosy: 30th Anniversary of World Health Assembly Resolution and WHO Global Leprosy Strategy 2021-2030 Are Opportunities to Accelerate Efforts against the Disease

Sasakawa Leprosy Initiative . 2021;
Download PDF
Publication

Características epidemiológicas e espaço-temporal de casos novos de hanseníase em municípios do estado de Alagoas, Brasil

Alves GMG, Melo GCD, Teixeira C, et al. Research, Society and Development. Research, Society and Development. 2021; 10 (5) : e48510514962.
Download PDF
Publication

One Health and Hansen's disease in Brazil.

Deps P, Rosa P. PLoS neglected tropical diseases. 2021; 15 (5) : e0009398.
Download PDF
Publication

Leprosy cases diagnosed by contacts examination in a hyperendemic capital city of northeastern Brazil.

Soares A, Corrêa RDGCF, Santos KCBD, et al. Anais brasileiros de dermatologia. 2021;
Download PDF
Publication

Structure-Guided Computational Approaches to Unravel Druggable Proteomic Landscape of Mycobacterium leprae.

Vedithi S, Malhotra S, Acebrón-García-de-Eulate M, et al. Frontiers in molecular biosciences. 2021;
Download PDF
Publication

Dapsone induced methemoglobinemia in leprosy: A close mimic of 'happy hypoxia' in the COVID-19 pandemic.

Tripathi T, Singh A, Kapoor R, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021;
Download PDF
Publication

Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review.

Hambridge T, Chandran S, Geluk A, et al. PLoS neglected tropical diseases. 2021; 15 (5) : e0009436.
Download PDF
Publication

An individual randomised efficacy trial of autologous blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in leprosy in Nepal: the TABLE trial protocol

Napit I, Shrestha D, Bishop J, et al. Research Square Platform LLC. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 279
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD